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LETTER TO THE EDITOR
REACTIVATION OF Trypanosoma cruzi INFECTION IN IMMUNOSUPPRESSED PATIENTS:
CONTRIBUTIONS FOR THE LABORATORIAL DIAGNOSIS STANDARDIZATION
São Paulo, October 2, 2007
Dear Sir,
Diagnosis of parasitemia associated with reactivation of Chagas
disease remains a challenge in clinical practice. Since 1990, criteria to
establish the differential diagnosis of chronic Chagas disease sporadic
parasitemia, and reactivation have been proposed in heart transplant
recipients including magnitude of parasitemia, severity of clinical
manifestations, evidence of miocarditis, and the finding of Trypanosoma
cruzi in tissues1. LUQUETTI & RASSI12 recommended searching for
parasites in fresh blood by means of QBC - Quantitative Buffy Coat,
Strout or micro-hematocrit whenever Chagas disease reactivation is
under suspicion, and in negative cases, investigation should continue
by means of xenodiagnosis with anticipation of microscopic
examination. More recently, SARTORI et al.17 have defined reactivation
as the presence of clinical manifestations that are not observed in
immunocompetent individuals with chronic T. cruzi infection: detection
of parasites by microscopy examination of blood or cerebrospinal fluid
(CSF); and high burdens of T. cruzi amastigotes in tissue biopsies or
biological samples collected during autopsies. The same authors
classified parasitemia in three categories according to microscopic
detection: very high parasitemia, high parasitemia and low parasitemia,
when T. cruzi was detected by direct examination of blood and/or CSF,
when ≥20% of triatomines fed on the patient’s blood were positive, or
< 20% of triatomines were positive, respectively (alternatively, in the
last case, when only blood culture gave a positive result).
The gold standard of Chagas disease laboratory diagnosis remains
xenodiagnosis and/or hemoculture10,14 even though the former still lacks
standardization after 90 years of existence, and the latter has got limited
sensitivity7,13. More recently, a number of studies have reported higher
sensitivities of the Polymerase Chain Reaction (PCR) in comparison
with xenodiagnosis and hemoculture5,6,8. However, none of the studies
was able to perform a metanalysis due to the heterogeneity of laboratory
techniques. Besides, there is still no standardization on the amount of
blood volume to be analyzed from each patient, either by xenodiagnosis
or hemocultures, and how many blood samplings have to be performed
in order to ensure a negative result10,14. In addition, there is also no
consensus on the superiority of minicircles (kDNA), or the genomic
DNA (TCZ sequence) as the best PCR target4,9,11,16,18. Both systems
appear to be specific and highly sensitive (detection of one parasite or
fractions), thus being suitable for PCR.
In 2006, our laboratory used a murine model of Chagas disease
presenting with low parasitemia at the time of triatomines feeding3. To
analyze samples, PCR was performed with primers chosen on the TCZ
sequence coupled to microscopy examination performed in the context
of xenodiagnosis. The aim was to detect T. cruzi DNA in Triatoma
infestans digestive tract samples as soon as possible after bugs feeding
on infected mice, in an attempt to mimic the situation found during
reactivation of Chagas disease in immunosuppressed patients. In each
of the time-points considered starting on day one until day 60 after
blood meal, bugs were more likely to be found PCR-positive than
positive by microscopy and, on day one post-feeding, infections were
only detected by PCR in 40% of insects. On the following days tested
within the first week after blood meal (2nd, 3rd, 4th and 5th days),
superiority of PCR was sustained, and detection occurred in 55%, 40%,
70% and 63% of insects, respectively. RUSSOMANDO et al.16, detected
positive-PCR (TCZ sequence), studying feces of triatomines fed with
infected monkeys blood, as soon as day two after bugs’ blood meal.
ROMAÑA & BRIONES15 succeeded in detecting T. cruzi in a human
model of acute Chagas disease beginning the investigation on day two
up to day ten after the insects’ blood meal. It is likely that the very
early PCR detection has occurred before parasites multiplication took
place in the insect organisms, thus representing forms that had been
ingested during feeding in infected mice. Nevertheless, earlier detection
of parasites might be of clinical relevance irrespective of the parasite
DNA origin (either from the blood meal itself, or originated from
replication of parasites that had been ingested during the blood meal),
because Chagas disease reactivation in immunosuppressed patients
constitutes a life threatening event, and should be promptly diagnosed
to increase survival rates.
Therefore, aside from previously defined conventional laboratorial
methods already used to diagnose Chagas disease reactivation
(Consenso Brasileiro em Doença de Chagas, 2005)2, we propose that
PCR should be performed directly from the patient’s fresh blood,
coupled to microscopy examination in the context of xenodiagnosis
and/or to hemoculture (depending on the laboratory infrastructure and
personnel expertise), in order to investigate reactivation in
immunosuppressed patients. We also propose to anticipate T. cruzi
detection by means of earlier tests beginning on day one after
triatomines feeding with the patient’s blood, followed by at least one
test (preferentially two other tests) performed within the first five days
after the patient’s blood sampling. It is possible that two or three tests
performed during the first week might impact the laboratory diagnosis
of Chagas disease. We also recommend analysis on intermediate days,
e.g., day 10 and/ or 15 (in our murine model corresponding to 60 and
65% of positive-PCR detection), as well as the maintenance of the
traditional xenodiagnosis microscopic examination performed on days
30 and 60 post-feeding (in our study corresponding to 78.9% and 68.4%
of positive-PCR detection), to enable comparison with previously
reported studies (Fig. 1).
It seems judicious that a considerable number of cases should be
analyzed simultaneously by qualitative PCR (kDNA and TCZ), and
conventional diagnostic methods to allow a better understanding of
the advantages and limitations of each of the techniques before starting
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T. cruzi quantification. Evaluation of parasite loads might, in a near
future, become the technique of choice to diagnose Chagas disease,
perform the follow-up of patients, and establish cure criteria.
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